Health
Reducing COVID-19 burden with monoclonal antibodies and vaccination – News-Medical.Net
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress…
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress the transmission of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and reduce the burden of coronavirus disease 2019 (COVID-19) more than vaccination alone.
The team’s modeling simulations suggested that the near-term use of monoclonal antibodies (mAbs) for early treatment and post-exposure prophylaxis (PEP) in combination…
-
General22 hours agoWondering about winter | The Spectator Australia
-
Noosa News21 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General20 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Business23 hours agoWiseTech shares lift off amid agreement with founder Richard White